HOME >> BIOLOGY >> NEWS
Viruses found in untreated city water

LA CROSSE, Wis. - Viruses from human sources occur in the La Crosse, Wisconsin municipal drinking water supply prior to its chlorination, according to a study published today in the scientific journal Applied and Environmental Microbiology. Although the city's treated water meets or exceeds state and federal standards for drinking water, researchers and public health officials agree that more study is needed to pinpoint sources of the viruses and to determine if some viruses are surviving chlorination and making people sick with diarrhea and vomiting.

The objective of the study, by Marshfield Clinic Research Foundation (MCRF) and the U.S. Geological Survey (USGS), was to determine whether the amount of Mississippi River water moving through the riverbank and infiltrating city wells was related to the frequency of virus detection in the wells.

"There is a misconception that groundwater is pure because it is filtered simply by the process of passing through the soil, but that isn't always the case," said Mark Borchardt, Ph.D., the study's lead investigator and a scientist in MCRF's National Farm Medicine Center. "Understanding viruses in groundwater is a research priority among drinking water professionals. La Crosse is leading the way and has the most extensive dataset of any community in the U.S. that uses groundwater as its drinking water source." Researchers tested 48 untreated water samples from six of the city's 15 wells to evaluate whether viruses were present in the raw water. Half of the water samples contained at least one type of gastrointestinal virus and 23 percent of the samples contained two or more virus types. The study found enteroviruses, rotavirus, hepatitis A virus and noroviruses. Besides noting the presence of these viruses with molecular testing methods, researchers attempted to culture the enteroviruses and hepatitis A viruses to see if they were infectious. None of the enteroviruses sampled were infectious, althoug
'"/>

Contact: Chris Schellpfeffer
cschell@lsb.com
608-251-7070
Marshfield Clinic
6-Oct-2004


Page: 1 2 3

Related biology news :

1. The sweet science: Viruses switch grip to gain upper hand
2. Viruses can jump between primates and humans, researchers warn
3. Viruses may one day help treat brain tumors
4. Waters off Washington state only second place in world where glass sponge reefs found
5. First new multiple sclerosis gene found in 30 years
6. Obesity found to be a risk factor for multiple myeloma
7. Antibody-altering protein found in developing B cells
8. New use for a cell toxin found to inhibit survival proteins in cancer cells
9. New way to target and kill antibiotic-resistant bacteria found
10. Soil particles found to boost prions capacity to infect
11. Support for chromosomal theory of cancer found in cancers development of drug resistance

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Viruses found untreated city water

(Date:3/20/2015)... and Markets ( http://www.researchandmarkets.com/research/vkzvcs/iris_biometrics ) has announced the ... Report" report to their offering. This report ... The report provides separate comprehensive analytics for the US, ... Europe , Asia-Pacific , ... . Annual estimates and forecasts are provided ...
(Date:3/17/2015)... , March 17, 2015  MecklerMedia Corporation ... largest exhibition for service robots ever held in ... takes place on May 11-13, 2015 at the ... exhibitors for the event include: Acorn Product Development; ... EZ-Robot; Infranor; Kinova Robotics; Littler; NewBotic Corporation; Neya ...
(Date:3/12/2015)... 2015 WHEN:Tuesday, March 17, 2015 at 11:00 ... . SPEAKERS: , Frost & Sullivan Measurement & ... Biometric companies must plan for ... different markets and industries. This is especially true ... Join Frost & Sullivan,s upcoming ...
Breaking Biology News(10 mins):Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 2Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 3Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 4Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 5MecklerMedia's RoboUniverse New York Announces Sponsors and Exhibitors, May 11-13, 2015 2Biometrics Key to Future Growth in Healthcare, Retail and Financial Markets 2Biometrics Key to Future Growth in Healthcare, Retail and Financial Markets 3
(Date:3/30/2015)... PMG Research, Benchmark Research, and Miami ... of VaxCorps, a network of highly experienced, geographically ... of vaccine trials in healthy adult, elderly, and ... conducted over 500 phase I-III vaccine clinical trials, ... as well as a vast array of other ...
(Date:3/30/2015)... 30, 2015  NuGene International, Inc. ("NuGene") (OTCQB: ... BioPharma, Inc. has added another internationally recognized researcher ... is an internationally recognized researcher in bio-inspired materials ... at Peking University, China , ... University of North Carolina, Chapel Hill. Following a ...
(Date:3/30/2015)... -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI ), a ... of innovative therapeutics addressing cancer and other unmet medical ... on China , announced today that ... the Company,s application to conduct a Phase 2 global ... for its proprietary drug candidate ENMD-2076.  ...
(Date:3/30/2015)... Md. , March 30, 2015  Spherix ... company committed to the fostering and monetization of ... v. VTech,  Case No. 3:13-cv-03494-M and  Spherix v. ... United States District Court for the Northern District ... update regarding Spherix v. Verizon, Case ...
Breaking Biology Technology:PMG Research announces formation of VaxCorps with two industry-leading vaccine site networks 2UCI Professor Zhibin Guan Joins NuGene Advisory Board 2UCI Professor Zhibin Guan Joins NuGene Advisory Board 3CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 2CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 3CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 4CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 5Spherix Provides Update on Litigation vs. VTech, Uniden and Verizon 2Spherix Provides Update on Litigation vs. VTech, Uniden and Verizon 3
Cached News: